Comera Life Sciences (CMRA) Competitors $0.0002 0.00 (0.00%) As of 08/29/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock CMRA vs. VRPX, SCPS, STAB, EVLO, SMFL, GNCAQ, GNCA, ARDS, PXMD, and CALAShould you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include Virpax Pharmaceuticals (VRPX), Scopus BioPharma (SCPS), Statera Biopharma (STAB), Evelo Biosciences (EVLO), Smart for Life (SMFL), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), PaxMedica (PXMD), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry. Comera Life Sciences vs. Its Competitors Virpax Pharmaceuticals Scopus BioPharma Statera Biopharma Evelo Biosciences Smart for Life Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals PaxMedica Calithera Biosciences Comera Life Sciences (NASDAQ:CMRA) and Virpax Pharmaceuticals (NASDAQ:VRPX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk. Does the media prefer CMRA or VRPX? In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Virpax Pharmaceuticals'average media sentiment score. Company Overall Sentiment Comera Life Sciences Neutral Virpax Pharmaceuticals Neutral Which has more volatility & risk, CMRA or VRPX? Comera Life Sciences has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500. Comparatively, Virpax Pharmaceuticals has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500. Is CMRA or VRPX more profitable? Comera Life Sciences' return on equity of 0.00% beat Virpax Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Comera Life SciencesN/A N/A N/A Virpax Pharmaceuticals N/A -1,554.34%-338.29% Which has stronger earnings and valuation, CMRA or VRPX? Virpax Pharmaceuticals has lower revenue, but higher earnings than Comera Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioComera Life Sciences$1.00M0.01-$18MN/AN/AVirpax PharmaceuticalsN/AN/A-$15.19MN/AN/A Do institutionals & insiders believe in CMRA or VRPX? 32.2% of Virpax Pharmaceuticals shares are held by institutional investors. 8.9% of Comera Life Sciences shares are held by insiders. Comparatively, 3.7% of Virpax Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend CMRA or VRPX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Comera Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Virpax Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryComera Life Sciences and Virpax Pharmaceuticals tied by winning 4 of the 8 factors compared between the two stocks. Get Comera Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMRA vs. The Competition Export to ExcelMetricComera Life SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6K$841.29M$5.76B$9.85BDividend YieldN/A4.84%6.66%4.49%P/E RatioN/A1.1482.4826.51Price / Sales0.0126.58500.41161.56Price / CashN/A19.5625.7028.92Price / BookN/A6.6710.816.51Net Income-$18M-$4.78M$3.28B$266.22M7 Day PerformanceN/A0.84%-0.43%-1.21%1 Month PerformanceN/A18.22%6.47%3.32%1 Year PerformanceN/A27.74%49.57%23.49% Comera Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002VRPXVirpax Pharmaceuticals0.1074 of 5 stars$0.01flatN/A-99.9%$14KN/A0.007SCPSScopus BioPharmaN/A$0.00-40.0%N/AN/A$13KN/A0.009Gap DownSTABStatera BiopharmaN/A$0.00+100.0%N/A-66.7%$11KN/A0.0020Gap UpEVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9KN/A0.00120Options VolumeSMFLSmart for LifeN/A$0.00+1,000.0%N/A-99.8%$8K$11.11M0.00110Gap UpGNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070ARDSAridis PharmaceuticalsN/AN/AN/AN/A$5KN/A0.0030PXMDPaxMedicaN/A$0.00+100.0%N/AN/A$2KN/A0.002Gap UpCALACalithera BiosciencesN/A$0.00flatN/A-99.5%$1KN/A0.0060 Related Companies and Tools Related Companies VRPX Competitors SCPS Competitors STAB Competitors EVLO Competitors SMFL Competitors GNCAQ Competitors GNCA Competitors ARDS Competitors PXMD Competitors CALA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMRA) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Comera Life Sciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Comera Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMRA Stock Alerts